Profil
Dr. Naisbitt brings a broad background in molecular biology, neuroscience and clinical medicine to RiverVest.
He serves as a board observer at Auxeris Therapeutics, Inc. and Kereos, Inc., both RiverVest portfolio companies.
Prior to joining RiverVest, Dr. Naisbitt was an associate of Seedling Enterprises, a medical device fund and incubator, where he performed early-stage investment diligence and product development.
He is co-inventor of a novel electrosurgical instrument successfully sold to a major pharmaceutical and medical device company.
Dr. Naisbitt worked in research labs at Harvard Medical School, Massachusetts General Hospital and the University of Utah.
He has 13 original research publications, including the cloning and elucidation of the first physical bridge coupling NMDA and metabotropic glutamate receptors to each other and to postsynaptic signaling molecules, essential mechanistic components of learning and memory.
Dr. Naisbitt holds an M.D.
and Ph.D.
from the Harvard-M.I.T.
Division of Health Sciences and Technology, where he was awarded an N.I.H.
Medical Scientist Training Program Scholarship from Harvard Medical School.
He also holds a B.S.
in physics and mathematics from the University of Utah.
Anciens postes connus de Scott Naisbitt
Sociétés | Poste | Fin |
---|---|---|
RiverVest Venture Management LLC
RiverVest Venture Management LLC Investment ManagersFinance RiverVest Venture Management LLC (RiverVest Venture Partners) is a venture capital firm founded in 2000 by Tom C. Melzer, Jay W. Schmelter, Mark J. Mendel and Andrew B. Craig III. The firm is headquartered in St. Louis, Missouri. | Private Equity Investor | 31/12/2008 |
Lutonix, Inc.
Lutonix, Inc. Medical SpecialtiesHealth Technology Lutonix, Inc. develops and commercializes drug coated balloon catheters. Its catheters help to deliver therapeutic dose of paclitaxel. The firm’s catheters are used to treat peripheral and coronary lesions. The company was founded in July 2007 by Dennis Wahr and Lixiao Wang and is headquartered in New Hope, MN. | Directeur Technique/Scientifique/R&D | - |
Formation de Scott Naisbitt
Harvard Mit Health Sciences & Technology | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
RiverVest Venture Management LLC
RiverVest Venture Management LLC Investment ManagersFinance RiverVest Venture Management LLC (RiverVest Venture Partners) is a venture capital firm founded in 2000 by Tom C. Melzer, Jay W. Schmelter, Mark J. Mendel and Andrew B. Craig III. The firm is headquartered in St. Louis, Missouri. | Finance |
Lutonix, Inc.
Lutonix, Inc. Medical SpecialtiesHealth Technology Lutonix, Inc. develops and commercializes drug coated balloon catheters. Its catheters help to deliver therapeutic dose of paclitaxel. The firm’s catheters are used to treat peripheral and coronary lesions. The company was founded in July 2007 by Dennis Wahr and Lixiao Wang and is headquartered in New Hope, MN. | Health Technology |